A new and innovative way to improve patients’ recoveries following colorectal surgery.
An innovative and secure solution for the protection of digestive anastomosis.
Invented by French surgeon Charam Khosrovani, Colovac is a flexible endoluminal bypass sheath that prevents contamination of the colorectal anastomotic site following open or laparoscopic colorectal surgery.
Who we are
Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy.
We are guided by compassion and empathy.
We are proud of our testimonials and comments we received from most valuable medical professionals.
Dr. Antonio D’Urso
Digestive surgery and bariatric at Hôpitaux Universitaires de Strasbourg, France
"In order to always improve the quality of life of our patients, our hospital has agreed to be part of the clinical study. I am a huge advocate of the Colovac: it enables to avoid diverting stoma, it is minimally invasive and fully reversible at any time."
Prof. Jérémie Lefevre
General Surgery at Hôpital Saint-Antoine, Paris-France
“The clinical results in this trial indicate that Colovac is an alternative to ileostomy, obviating the burden of stoma care for patients with a rectal cancer.”
Dr. Patricia Sylla
Colon and Rectal Surgery at Mount Sinai, New York-USA
"There is a clinical need, Colovac’s approaching the problem from a different angle. For the patient, there is an immediate added value: avoiding an ostomy, it is an added value, no matter what."
Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the...Read More
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery.Read More
- SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States : Click here to read the press release
SafeHeal lève 40 M€ lors d’un tour de table mené par Sofinnova Partners et Genesis Medtech Group pour financer l’étude clinique pivot de son produit Colovac : Cliquez ici pour lire le communiqué
- Video: Innovations Santé